Catalyze: Enabling Technologies and Transformative Platforms for HLBS Research
Funds rigorously validating a transformative, multi-use platform or technology aimed at heart, lung, blood or sleep disease.
A platform technology that could serve many different diagnostic or treatment purposes is a hard thing to fund through an ordinary disease-specific grant — it does not belong to one application. This notice is where NHLBI's Catalyze Program puts that kind of work.
The Catalyze Program overall exists to move basic science discoveries toward diagnostic and therapeutic candidates ready for human tes…
Rigorous validation of transformative, multi-use platforms or technologies with the potential to improve early detection and screening, model development, clinical diagnosis, treatment, control, behaviour, prevention or epidemiology for heart, lung, blood or sleep disease, under NHLBI's Catalyze Program.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see what you submit
Sign up free to see how they score you
Sign up free to see the timeline
Sign up free to see where teams trip up
Guides for this application
All guides →NIH Biosketch Guide: Format, SciENcv Steps, and Examples
Learn what an NIH biosketch is, how the format works, what to prepare for SciENcv, and how startup teams should avoid common biosketch mistakes.
Write proposalHow to Write a Specific Aims Page
Learn how to write a specific aims page for NIH, SBIR-adjacent, and translational R&D grants, with structure, reviewer logic, examples, and common mistakes.
Where to applyGrants for Biotech Startups: NIH, NSF, SBIR/STTR, and Non-Dilutive Funding
A practical guide to grants for biotech startups, including NIH SBIR/STTR, NSF, translational funding, evidence, regulatory readiness, and budgets.
Write proposalHow to Write a Grant Proposal Reviewers Can Score
Learn how to write a grant proposal around reviewer criteria, evidence, work packages, budget logic, and commercialization for deeptech and R&D funding.
More from NIH
All grants from this funder →Advanced Development of Informatics Technologies for Cancer Research and Management
NIH · United States
Funds the enhancement of a cancer informatics tool that has cleared prototyping, shows real promise, and has not yet been widely adopted.
Community Engagement Evaluation and Data Coordination (CEED) Hub to Advance Data and Practice Transformation for Optimizing Oral Health for All
🇺🇸NIH · United States
Funds a single hub that coordinates data, evaluation and operations for a consortium of community-based oral health research projects.
Limited Competition: Small Grant Program for the NCATS Clinical and Translational Science Award (CTSA) Program (R03)
🇺🇸NIH · United States
Funds one small self-contained project for a scholar already inside the Clinical and Translational Science Award network, on the way to a first full award.
Model-to-Clinic (M2C) for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI)
NIH · United States
Funds the move of an imaging-centred multimodal AI tool from a trained and tested prototype towards real clinical use, as regulated device software.
PRIMED-AI: Data-to-Model Academic-Industrial Partnerships (D2M-AIP) for Precision Medicine with AI: Integrating Imaging with Multimodal Data
NIH · United States
Funds a company and an academic team to build and test an imaging-centred multimodal AI decision tool, developed as software that is a medical device.
Sustained Support for Informatics Technologies for Cancer Research and Management
NIH · United States
Funds the running costs and continued relevance of a cancer informatics tool that researchers already depend on.
Similar grants
Browse the directory →
CFF Clinical Research Award
🇺🇸CFF · United States
Supports investigator-driven clinical studies addressing diagnosis, treatment, and prevention across key medical priorities.
CRI Technology Impact Award
CRI · United States
Pays tenure-track researchers up to $600,000 to build unproven cancer immunotherapy technology.
Efficient and Innovative Natural History Studies Addressing Unmet Needs in Rare Diseases
🇺🇸FDA OOPD · United States
Funds natural-history studies that improve preparedness for rare disease trial pathways.
NCATS Clinical Trial Readiness for Rare Diseases
🇺🇸NCATS · United States
Funds U.S. researchers and companies generating natural history data, biomarkers, and outcome measures needed to design clinical trials for rare diseases.
NCI Bioengineering Research Grants (BRG)
🇺🇸NCI · United States
Supports bioengineering teams tackling cancer by connecting life and physical science groups.
Prevention and Intervention Approaches for FASD (R34)
🇺🇸NIAAA · United States
Supports FASD prevention and intervention planning studies to establish feasibility and practical research direction.